People taking insulin injections may have constipation, and those taking semaglutide injections may experience nausea, vomiting, diarrhea, and stomach pain
doi: 10.1080/14656566.2019.1571040 122 GenoveseSMannucciECerielloA
For patients pursuing weight management with GLP-1 therapy, addressing concurrent stress and sleep issues optimizes treatment outcomes
Ki67 antigen expression correlates with tumor progression and HLA-DR antigen expression in melanocytic lesions
It can help you reach your goals, whether that includes weight loss, blood sugar control, or better heart health
Hair loss appeared more frequently among users of two drugs in particular: Semaglutide: 199 cases Tirzepatide: 179 cases For the remaining GLP1 medications, no elevated signal emerged: liraglutide (20 cases), dulaglutide (65 cases), exenatide (6 cases), and lixisenatide (0 cases)